How much of a cancer drug do patients need? U. of C. doctor, others challenge the FDA, drugmakers on dosing.

First publishedAug 20, 18:51 UTC

Last updatedAug 20, 20:08 UTC · 11m ago

118:51–18:54 UTC1 outletChicago Sun-Times

18:5119:1019:3019:4920:08

Chicago Sun-Times6How much of a cancer drug do patients need? U. of C. doctor, others challenge the FDA, drugmakers on dosing.Aug 20, 18:51 UTCOpen ↗

1 outlets over time — hover a bar for its window & outletslast updated

Reported by 1 outlet — Chicago Sun-Times. See all sources ↓

<p>Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill.</p><p>For six months in 2022, Manski received monthly infusions of nivolumab to fight advanced melanoma. The drug ruined his thyroid gland, he said, requiring him to go on a special medication for the rest of his life, and caused severe dryness in his eyes, lips and mouth.</p><p>The federal Food and Drug Administration’s protocol for the drug called for an entire year of treatment, but Manski said his oncologist couldn’t explain why. It’s FDA-approved, “so that’s what we use,” he said he was told.</p><p>By that point, Manski showed no cancer signs or symptoms.

Read the full report at Chicago Sun-Times ↗

• Coverage card1 outlet

  1Coverage

  

  Outlet lineup

  Scouting report

  How much of a cancer drug do patients need? U. of C. doctor, others challenge the FDA, drugmakers on dosing.

  Sources1

  TypeCoverage

  Chicago Sun-TimesAug 20, 18:51

• Chicago Sun-Times6↗